Cargando…
Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: Analysis of clinical trials of human rotavirus vaccine
Clinical trials of the human rotavirus vaccine Rotarix™ (RV1) have demonstrated significant reductions in severe rotavirus gastroenteritis (RVGE) in children worldwide. However, no correlate of vaccine efficacy (VE) has yet been established. This paper presents 2 analyses which aimed to investigate...
Autores principales: | Cheuvart, Brigitte, Neuzil, Kathleen M, Steele, A Duncan, Cunliffe, Nigel, Madhi, Shabir A, Karkada, Naveen, Han, Htay Htay, Vinals, Carla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185910/ https://www.ncbi.nlm.nih.gov/pubmed/24240068 http://dx.doi.org/10.4161/hv.27097 |
Ejemplares similares
-
Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination
por: Steele, A. Duncan, et al.
Publicado: (2016) -
The human rotavirus vaccine Rotarix™ in infants: An integrated analysis of safety and reactogenicity
por: Buyse, Hubert, et al.
Publicado: (2014) -
Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial
por: Steele, Andrew Duncan, et al.
Publicado: (2012) -
Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414
por: Cunliffe, Nigel, et al.
Publicado: (2014) -
Duration and Density of Fecal Rotavirus Shedding in Vaccinated Malawian Children With Rotavirus Gastroenteritis
por: Bennett, Aisleen, et al.
Publicado: (2019)